Table 2. Features of participants at baseline.
Feature | Total (%) n=17(100) | |
---|---|---|
Sociodemographic | Gender | |
Male | 5 (29.4) | |
Female | 12 (70.5) | |
Average age | 61.4 ± 6* | |
Socioeconomic status | Low 2–3 | 9 (47) |
Medium/High 4–5 | 8 (52.9) | |
Schooling | Primary | 6 (35.2) |
Secondary | 4 (23.5) | |
Technical/ University | 7 (41.1) | |
Anthropometric | BMI | |
Not overweight (BMI 25) | 2 (11.7) | |
Overweight (BM >25 and ˂30) | 6 (35.2) | |
Obesity (BM >30) | 9 (52.9) | |
Dominant extremity | Right | 14 (82.3) |
Left | 3 (17.6) | |
Involvement | Unilateral | 4 (23.5) |
Bilateral | 13 (76.4) | |
Ingestion of analgesics | Yes | 11 (64.8) |
No | 6 (35.2) | |
Type of analgesics | NSAIDs | 5 (29.4) |
Non-NSAIDs | 2 (11.7) | |
Opioids | 0 | |
Other | 4 (23.5) | |
None | 6 (35.2) | |
Level of physical activity (%) | Low | 6 (35.2) |
Moderate | 6 (35.2) | |
Vigorous | 5 (29.4) | |
Severity of OA | Grade ll | 11 (64.7) |
Grade lll | 6 (35.3) | |
Patellofemoral OA | Present | 16 (94.1) |
Absent | 1 (5.8) |
*Median ± standard deviation (SD), BMI: body mass index; n: sample size